| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |